Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance

M. Cristina Polidori, Ludger Pientka, Gereon Nelles, Helen R. Griffiths

Research output: Contribution to journalArticle

Abstract

General practitioners, geriatricians, neurologists and health care professionals all over the world will be facing by 2040 the diagnostic, therapeutic and socioeconomic challenges of over 80 million people with dementia. Dementia is one of the most common diseases in the elderly which drastically affects daily life and everyday personal activities, is often associated with behavioural symptoms, personality change and numerous clinical complications and increases the risk for urinary incontinence, hip fracture, and - most markedly - the dependence on nursing care. The costs of care for patients with dementia are therefore immense. Serum cholesterol levels above 6.5 mmol/L are known to be associated with an increased RR of 1.5 and 2.1 to develop Alzheimeŕs disease, the most common form of dementia, and a reduction of serum cholesterol in midlife is associated with a lowered dementia risk. The aim of this work is to critically discuss some of the main results reported recently in the literature in this respect and to provide the pathophysiological rationale for the control of dyslipidemia in the prevention of dementia onset and progression.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalInternational Journal of Clinical and Experimental Medicine
Volume3
Issue number2
Early online date20 Apr 2010
Publication statusPublished - 18 Aug 2010

Fingerprint

Oxidation-Reduction
Dementia
Aging of materials
Cholesterol
Modulation
Nursing
Health care
Costs
Behavioral Symptoms
Hip Fractures
Urinary Incontinence
Dyslipidemias
Nursing Care
Serum
General Practitioners
Personality
Patient Care
Delivery of Health Care
Costs and Cost Analysis

Keywords

  • ageing
  • cholesterol
  • cognition
  • LDL
  • oxidation

Cite this

Polidori, M. Cristina ; Pientka, Ludger ; Nelles, Gereon ; Griffiths, Helen R. / Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance. In: International Journal of Clinical and Experimental Medicine. 2010 ; Vol. 3, No. 2. pp. 103-109.
@article{44a0516241f54e92b213b4e3d3665c5c,
title = "Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance",
abstract = "General practitioners, geriatricians, neurologists and health care professionals all over the world will be facing by 2040 the diagnostic, therapeutic and socioeconomic challenges of over 80 million people with dementia. Dementia is one of the most common diseases in the elderly which drastically affects daily life and everyday personal activities, is often associated with behavioural symptoms, personality change and numerous clinical complications and increases the risk for urinary incontinence, hip fracture, and - most markedly - the dependence on nursing care. The costs of care for patients with dementia are therefore immense. Serum cholesterol levels above 6.5 mmol/L are known to be associated with an increased RR of 1.5 and 2.1 to develop Alzheimeŕs disease, the most common form of dementia, and a reduction of serum cholesterol in midlife is associated with a lowered dementia risk. The aim of this work is to critically discuss some of the main results reported recently in the literature in this respect and to provide the pathophysiological rationale for the control of dyslipidemia in the prevention of dementia onset and progression.",
keywords = "ageing, cholesterol, cognition, LDL, oxidation",
author = "Polidori, {M. Cristina} and Ludger Pientka and Gereon Nelles and Griffiths, {Helen R.}",
year = "2010",
month = "8",
day = "18",
language = "English",
volume = "3",
pages = "103--109",
journal = "International Journal of Clinical and Experimental Medicine",
issn = "1940-5901",
publisher = "e-Century Publishing Corporation",
number = "2",

}

Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance. / Polidori, M. Cristina; Pientka, Ludger; Nelles, Gereon; Griffiths, Helen R.

In: International Journal of Clinical and Experimental Medicine, Vol. 3, No. 2, 18.08.2010, p. 103-109.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balance

AU - Polidori, M. Cristina

AU - Pientka, Ludger

AU - Nelles, Gereon

AU - Griffiths, Helen R.

PY - 2010/8/18

Y1 - 2010/8/18

N2 - General practitioners, geriatricians, neurologists and health care professionals all over the world will be facing by 2040 the diagnostic, therapeutic and socioeconomic challenges of over 80 million people with dementia. Dementia is one of the most common diseases in the elderly which drastically affects daily life and everyday personal activities, is often associated with behavioural symptoms, personality change and numerous clinical complications and increases the risk for urinary incontinence, hip fracture, and - most markedly - the dependence on nursing care. The costs of care for patients with dementia are therefore immense. Serum cholesterol levels above 6.5 mmol/L are known to be associated with an increased RR of 1.5 and 2.1 to develop Alzheimeŕs disease, the most common form of dementia, and a reduction of serum cholesterol in midlife is associated with a lowered dementia risk. The aim of this work is to critically discuss some of the main results reported recently in the literature in this respect and to provide the pathophysiological rationale for the control of dyslipidemia in the prevention of dementia onset and progression.

AB - General practitioners, geriatricians, neurologists and health care professionals all over the world will be facing by 2040 the diagnostic, therapeutic and socioeconomic challenges of over 80 million people with dementia. Dementia is one of the most common diseases in the elderly which drastically affects daily life and everyday personal activities, is often associated with behavioural symptoms, personality change and numerous clinical complications and increases the risk for urinary incontinence, hip fracture, and - most markedly - the dependence on nursing care. The costs of care for patients with dementia are therefore immense. Serum cholesterol levels above 6.5 mmol/L are known to be associated with an increased RR of 1.5 and 2.1 to develop Alzheimeŕs disease, the most common form of dementia, and a reduction of serum cholesterol in midlife is associated with a lowered dementia risk. The aim of this work is to critically discuss some of the main results reported recently in the literature in this respect and to provide the pathophysiological rationale for the control of dyslipidemia in the prevention of dementia onset and progression.

KW - ageing

KW - cholesterol

KW - cognition

KW - LDL

KW - oxidation

UR - http://www.scopus.com/inward/record.url?scp=77955544686&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 103

EP - 109

JO - International Journal of Clinical and Experimental Medicine

JF - International Journal of Clinical and Experimental Medicine

SN - 1940-5901

IS - 2

ER -